InvestorsHub Logo
Followers 23
Posts 2445
Boards Moderated 0
Alias Born 03/15/2007

Re: goodJohnhunting post# 185280

Tuesday, 08/05/2014 10:20:12 AM

Tuesday, August 05, 2014 10:20:12 AM

Post# of 346631
What ever came of this?

And This?

Peregrine Pharmaceuticals establishes a new Anti-Viral Research Group

Published on October 7, 2009

Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) today announced that it has established a new Anti-Viral Research Group in its R&D organization. The new group has responsibility for coordinating, expanding and leveraging the company's multiple external collaborations already underway or planned to assess the potential utility of Peregrine's phosphatidylserine (PS)-targeting antibody platform for the prevention and treatment of a broad range of serious infectious diseases, including viral hemorrhagic fevers (VHF) and other biodefense threats, HIV, influenza, cytomegalovirus (CMV), leishmaniasis and malaria.

Dr. Amy Brideau-Andersen will be directing the new Anti-Viral Research Group.


http://www.news-medical.net/news/20091007/Peregrine-Pharmaceuticals-establishes-a-new-Anti-Viral-Research-Group.aspx


Anyone know if Dr. Amy Brideau-Andersen is still with PPHM?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News